摘要
激活素A是一种多功能细胞因子，具有广泛生物学作用，其在肝脏的作用主要表现为抑制细胞增殖、诱导细胞凋亡、促进细胞外基质分泌、抑制肿瘤细胞增殖及转移。在慢性肝炎、肝纤维化、肝癌及肝功能衰竭等疾病发生发展过程中均有激活素A表达异常，提示激活素A信号异常可能参与了肝脏疾病发生发展过程。
出处
《临床肝胆病杂志》
CAS
2006年第4期314-315,共2页
Journal of Clinical Hepatology
参考文献16
-
1Luisi S,Florio P,Reis FM,et al.Expression and secretion of activin A:possible physiological and clinical implications[J].Eur J Endocrinol,2001,145(3):225 -236.
-
2Chen YG,Lui HM,Lin SL,et al.Regulation of cell proliferation,apoptosis,and Carcinogenesis by activin[J].Experimental Biology and Medicine,2002,227(2):75 -87.
-
3Locaputo S,Carrick TL,Bezerra JA.Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice[J].Hepatology,1999,29(4):1106-1113.
-
4Hughes RD,Evans LW.Activin A and follistatin in acute liver failure[J].Eur J Gastroenterol Hepatol,2003,15 (2):127-131.
-
5Patella S,Phillips DJ,de Kretser DM,et al.Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis[J].J Hepatol,2001,34(4):576-583.
-
6Sugiyama M,Ichida T,Sato T,et al.Expression of activin A is increased in cirrhotic and fibrotic rat livers[J].Gastroenterology,1998,114(3):550-558.
-
7Date M,Matsuzaki K,Matsushita M,et al.Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury[J].J Hepatol,2000,32(2):251-260.
-
8Rossmanith W,Chabicovsky M,Grasl-Kraupp B,et al.Follistatin over-expression in rodent liver tumors:a possible mechanism to overcome activin growth control[J].Mol Carcinog,2002,35(1):1-5.
-
9Lee DK,Park SH,Yi Y,et al.The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4:potential mechanism of hepatitis B virus-induced liver fibrosis[J].Genes Der,2001,15 (4):455-466.
-
10Caselitz M,Chavan A,Manns MP,et al.Hereditary hemorrhagic telangiectasia (Osler-Reudu-Weber disease) and its manifestation in the liver[J].Z Gastroenterol,2001,39(7):533 -542.
同被引文献5
-
1张红军,台桂香,杨清,柳忠辉.激活素在肝纤维化形成中的作用[J].临床肝胆病杂志,2007,23(3):232-234. 被引量：8
-
2MI LJ,MAK KM,LIEBER CS.Attenuation of alcohol-induced apoptosis of hepatocytes in rat livers by polyenylphosphatidylcholine (PPC)[J].Alcohol clin Exp Res 2000,24(2):207.
-
3TSUCHIDA K,NAKATANI M,MATSUZAKI T.Novel factors in regulation of activin signaling[J].Mol cell Endocrinol,2004,225:1.
-
4Mi LJ,Mak KM,Lieber CS.Attenuation of alcohol-induced apoptosis of hepatocytes in rat livers by polyenylphosphatidylcholine (PPC)[J].Alcohol clin Exp Res,2000,24(2):207.
-
5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14010
引证文献4
-
1孔祥民,刘忠艳,傅春彬,杨清.慢性乙肝患者血清ACTA水平及临床评价[J].临床消化病杂志,2009,21(3):164-165. 被引量：1
-
2杨清,张晓娜,王胜.酒精性肝硬化患者血清激活素A水平及临床评价[J].中国实验诊断学,2009,13(12):1780-1781.
-
3杨清,韩树海,张晓娜,王胜.慢性乙型肝炎患者血清激活素A水平及临床评价[J].检验医学与临床,2010,7(21):2356-2357.
-
4崔国翠,张晓娜,李大光,陈勃,张灵敏,杨清.儿童乙型肝炎患者血清ACTA水平的变化及临床意义[J].中国妇幼保健,2012,27(7):1025-1026.
-
1罗淼,罗载刚.肝细胞生长因子与肺疾病[J].国外医学（呼吸系统分册）,2004,24(6):420-423.
-
2沈健,李光明,李定国.激活素A与肝脏疾病[J].国际内科学杂志,2007,34(4):210-212. 被引量：2
-
3王建礼,商战平,王家富.巨噬细胞移动抑制因子与动脉粥样硬化[J].医学综述,2007,13(13):967-969. 被引量：1
-
4蒋欣,张国华,高瑞利,张宏炜.巨噬细胞移动抑制因子与动脉粥样硬化及其相关疾病[J].国际脑血管病杂志,2007,15(12):931-934.
-
5张齐武,陈萍.白介素-6与支气管哮喘[J].沈阳部队医药,1998,11(1):72-74.
-
6王慧梅.α-2b干扰素治疗慢性乙型肝炎不良反应的护理[J].全科护理,2008,6(28):2591-2592.
-
7刘红.基因、信号调控异常与再生障碍性贫血的发病及治疗[J].南通大学学报（医学版）,2008,28(1):1-4.
-
8石顺祥,王学汉.干扰素-γ对大鼠慢性胰腺炎转化生长因子-β1表达和病理进展的影响[J].中华实验外科杂志,2008,25(8):1083-1083.
-
9邱玉琴.慢性乙肝患者使用干扰素治疗中不良反应的观察与护理[J].医学理论与实践,2011,24(8):963-964. 被引量：11
-
10陈凯红,刘海肃,沙安莉,谢志萍,裴豪,张波.病毒性肝炎患者血清白细胞介素-6值的观察[J].实用肝脏病杂志,1997,2(3):164-165.
